Ocular Therapeutix Inc (OCUL)
5.85
-1.73
(-22.82%)
USD |
NASDAQ |
Apr 18, 16:00
5.84
-0.01
(-0.17%)
After-Hours: 20:00
Ocular Therapeutix Gross Profit Margin (Quarterly): 90.64% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 90.64% |
| September 30, 2023 | 90.87% |
| June 30, 2023 | 91.41% |
| March 31, 2023 | 90.92% |
| December 31, 2022 | 92.81% |
| September 30, 2022 | 91.03% |
| June 30, 2022 | 90.58% |
| March 31, 2022 | 90.14% |
| December 31, 2021 | 91.00% |
| September 30, 2021 | 89.22% |
| June 30, 2021 | 90.65% |
| March 31, 2021 | 87.85% |
| December 31, 2020 | 90.75% |
| September 30, 2020 | 92.34% |
| June 30, 2020 | 91.46% |
| March 31, 2020 | 68.61% |
| December 31, 2019 | 62.81% |
| September 30, 2019 | 2.77% |
| June 30, 2019 | 15.08% |
| March 31, 2019 | 73.98% |
| Date | Value |
|---|---|
| December 31, 2018 | 76.79% |
| September 30, 2018 | 76.91% |
| June 30, 2018 | 76.39% |
| March 31, 2018 | 76.47% |
| December 31, 2017 | 76.80% |
| September 30, 2017 | 76.10% |
| June 30, 2017 | 76.26% |
| March 31, 2017 | 75.79% |
| December 31, 2016 | 75.15% |
| September 30, 2016 | 76.52% |
| June 30, 2016 | 76.19% |
| March 31, 2016 | 78.38% |
| December 31, 2015 | 78.90% |
| September 30, 2015 | 78.79% |
| June 30, 2015 | 82.57% |
| March 31, 2015 | 86.85% |
| December 31, 2014 | 94.06% |
| September 30, 2014 | 77.62% |
| June 30, 2014 | 79.38% |
| March 31, 2014 | 66.67% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
2.77%
Minimum
Sep 2019
92.81%
Maximum
Dec 2022
79.52%
Average
90.65%
Median
Jun 2021
Gross Profit Margin (Quarterly) Benchmarks
| Assertio Holdings Inc | 70.53% |
| CytomX Therapeutics Inc | -- |
| Regeneron Pharmaceuticals Inc | 84.95% |
| Cormedix Inc | -- |
| Verastem Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -274.3% |
| Return on Assets | -49.54% |
| Return on Invested Capital | -87.75% |
| Profit Margin (Quarterly) | -197.4% |
| Operating Margin (Quarterly) | -135.5% |
| Return on Net Operating Assets | -178.8% |